arrow
L

Lioe-Fee de Geus-Oei

department of radiology
H指数:47
被引数:1.1万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

No reinduction of clinically relevant radioiodine uptake after lenvatinib treatment in radioidine-refractory differentiated thyroid cancer

在接受放射性碘难治性分化型甲状腺癌患者中,lenvatinib治疗后未观察到临床相关的再次诱导放射性碘摄取。

2025-12-160
OAAI
Multicollinearity and redundancy of the PET radiomic feature set

PET影像组学特征集的多重共线性与冗余性

2025-05-070
OA
Head-to-head comparison of fibroblast activation protein inhibitors (FAPI) radiopharmaceuticals and [18F]FDG in gynaecological malignancies: systematic literature review and meta-analysis

头对头比较成纤维细胞活化蛋白抑制剂(FAPI)放射性药物与[18F]FDG在妇科恶性肿瘤中的研究:系统文献综述和荟萃分析

2025-04-250
OA
Assessment of fully quantitative and simplified methods for analysis of [68Ga]Ga-FAPI-46 uptake in patients with pancreatobiliary cancer using LAFOV PET/CT
2025-01-020
PRE
Role of [18F]FDG PET/CT in patients with invasive breast carcinoma of no special type: Literature review and comparison between guidelines

[18F]FDG PET/CT在非特殊类型浸润性乳腺癌患者中的作用: 文献回顾和指南比较

BREAST
IF7.9
2024-12-011
OAAI
Preoperative [18F]fluoro-PEG-folate PET/CT in advanced stage epithelial ovarian cancer: A safety and feasibility study
2024-11-010
OAAI
Challenges in Pharmacokinetic Modelling of [18F]fluoro-PEG-folate PET/CT Imaging in Epithelial Ovarian Cancer Patients
2024-05-221
OAAI
Joint EANM-SNMMI guideline on the role of 2-[18F]FDG PET/CT in no special type breast cancer (endorsed by the ACR, ESSO, ESTRO, EUSOBI/ESR, and EUSOMA)
2024-05-1414
OAAI